Literature DB >> 15642349

Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca(2+) elevation.

Kimiko Mogami1, Hiroko Kishi, Sei Kobayashi.   

Abstract

Neutral sphingomyelinase (N-SMase) elevated nitric oxide (NO) production without affecting intracellular Ca(2+) concentration ([Ca(2+)](i)) in endothelial cells in situ on aortic valves, and induced prominent endothelium-dependent relaxation of coronary arteries, which was blocked by N(omega)-monomethyl-L-arginine, a NO synthase (NOS) inhibitor. N-SMase induced translocation of endothelial NOS (eNOS) from plasma membrane caveolae to intracellular region, eNOS phosphorylation on serine 1179, and an increase of ceramide level in endothelial cells. Membrane-permeable ceramide (C(8)-ceramide) mimicked the responses to N-SMase. We propose the involvement of N-SMase and ceramide in Ca(2+)-independent eNOS activation and NO production in endothelial cells in situ, linking to endothelium-dependent vasorelaxation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642349     DOI: 10.1016/j.febslet.2004.11.100

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Cellular and tissue localization of globotriaosylceramide in Fabry disease.

Authors:  Hasan Askari; Christine R Kaneski; Cristina Semino-Mora; Priya Desai; Agnes Ang; David E Kleiner; Lorah T Perlee; Martha Quezado; Linda E Spollen; Brandon A Wustman; Raphael Schiffmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

Authors:  Dachun Yang; Zhidan Luo; Shuangtao Ma; Wing Tak Wong; Liqun Ma; Jian Zhong; Hongbo He; Zhigang Zhao; Tingbing Cao; Zhencheng Yan; Daoyan Liu; William J Arendshorst; Yu Huang; Martin Tepel; Zhiming Zhu
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

Review 3.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

4.  Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue.

Authors:  Leonardo F Ferreira; Jennifer S Moylan; Laura A A Gilliam; Jeffrey D Smith; Mariana Nikolova-Karakashian; Michael B Reid
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-02       Impact factor: 4.249

Review 5.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

Review 6.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

7.  Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.

Authors:  Jean Bismuth; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Med Sci Monit       Date:  2009-09

8.  Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide.

Authors:  Léon J A Spijkers; Rob F P van den Akker; Ben J A Janssen; Jacques J Debets; Jo G R De Mey; Erik S G Stroes; Bert-Jan H van den Born; Dayanjan S Wijesinghe; Charles E Chalfant; Luke MacAleese; Gert B Eijkel; Ron M A Heeren; Astrid E Alewijnse; Stephan L M Peters
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

Review 9.  A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

Review 10.  Neutral sphingomyelinase-2 and cardiometabolic diseases.

Authors:  Sardar Sindhu; Yat Hei Leung; Hossein Arefanian; S R Murthy Madiraju; Fahd Al-Mulla; Rasheed Ahmad; Marc Prentki
Journal:  Obes Rev       Date:  2021-03-18       Impact factor: 9.213

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.